Grünenthal GmbH
- Country
- 🇩🇪Germany
- Ownership
- Private
- Established
- 1946-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.grunenthal.com
Pharmacokinetic, Efficacy and Safety Study of Tapentadol Oral Solution in Children With Postoperative Pain
- First Posted Date
- 2012-11-20
- Last Posted Date
- 2019-11-04
- Lead Sponsor
- Grünenthal GmbH
- Target Recruit Count
- 86
- Registration Number
- NCT01729728
- Locations
- 🇺🇸
Jean Brown Research, Salt Lake City, Utah, United States
A Study to Assess the Safety and Efficacy of 7 Days Treatment With a Novel Analgesic in Subjects With Peripheral Neuropathic Pain
- Conditions
- Interventions
- First Posted Date
- 2011-12-05
- Last Posted Date
- 2019-10-28
- Lead Sponsor
- Grünenthal GmbH
- Target Recruit Count
- 114
- Registration Number
- NCT01485094
- Locations
- 🇵🇱
POL004, Lublin, Poland
🇭🇺HUN008, Szikszo, Hungary
🇭🇺HUN003, Győr, Hungary
Intravenous Tapentadol in Post-Bunionectomy Pain
- First Posted Date
- 2011-09-16
- Last Posted Date
- 2019-10-28
- Lead Sponsor
- Grünenthal GmbH
- Target Recruit Count
- 177
- Registration Number
- NCT01435577
- Locations
- 🇺🇸
Jean Brown Research, Salt Lake City, Utah, United States
Comparison of Increasing Doses of Tapentadol Versus a Combination of Tapentadol and Pregabalin
- First Posted Date
- 2011-05-12
- Last Posted Date
- 2019-10-28
- Lead Sponsor
- Grünenthal GmbH
- Target Recruit Count
- 622
- Registration Number
- NCT01352741
- Locations
- 🇵🇱
Site 306, Ostrów Mazowiecka, Poland
🇦🇹Site 504, Wien, Austria
🇦🇹Site 505, Wien, Austria
Tapentadol in Chronic Malignant Tumour Related Pain
- First Posted Date
- 2010-12-22
- Last Posted Date
- 2019-11-04
- Lead Sponsor
- Grünenthal GmbH
- Target Recruit Count
- 31
- Registration Number
- NCT01264887
- Locations
- 🇧🇬
Site 359004, Shumen, Bulgaria
🇲🇩Site 373001, Chisinau, Moldova, Republic of
🇭🇺Site 036010, Szekszard, Hungary
Lidocaine 5% Medicated Plaster in Chronic Neuropathic Postoperative Pain
- Conditions
- Interventions
- First Posted Date
- 2010-07-02
- Last Posted Date
- 2019-10-16
- Lead Sponsor
- Grünenthal GmbH
- Target Recruit Count
- 74
- Registration Number
- NCT01155986
- Locations
- 🇫🇷
Site 31, Abbeville, France
🇫🇷Site 17, Limoges, France
🇫🇷Site 26, Bayonne, France
A Trial in Painful Diabetic Peripheral Neuropathy With GRT3983Y
- First Posted Date
- 2010-01-26
- Last Posted Date
- 2019-10-28
- Lead Sponsor
- Grünenthal GmbH
- Target Recruit Count
- 553
- Registration Number
- NCT01056315
- Locations
- 🇺🇸
Site 209, Fullerton, California, United States
🇺🇸Site 136, Deerfield Beach, Florida, United States
🇺🇸Site 137, Deerfield Beach, Florida, United States
Efficacy and Safety of EN3324 (Axomadol) in Subjects With Chronic Low Back Pain
- First Posted Date
- 2010-01-06
- Last Posted Date
- 2015-04-02
- Lead Sponsor
- Grünenthal GmbH
- Target Recruit Count
- 236
- Registration Number
- NCT01043263
- Locations
- 🇺🇸
Comprehensive Clinical Research, Berlin, New Jersey, United States
🇺🇸Paradigm Clinical, Tucson, Arizona, United States
🇺🇸Beacon Clinical Research LLC, Brockton, Massachusetts, United States
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking WHO Step III Analgesics But Showing a Lack of Tolerability
- Conditions
- Interventions
- First Posted Date
- 2009-09-29
- Last Posted Date
- 2019-01-09
- Lead Sponsor
- Grünenthal GmbH
- Target Recruit Count
- 136
- Registration Number
- NCT00986258
- Locations
- 🇧🇪
BE004, Brugge, Belgium
🇵🇱PL002, Krakow, Poland
🇨🇭CH002, St. Gallen, Switzerland
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
- Conditions
- Interventions
- First Posted Date
- 2009-09-24
- Last Posted Date
- 2019-01-15
- Lead Sponsor
- Grünenthal GmbH
- Target Recruit Count
- 208
- Registration Number
- NCT00983385
- Locations
- 🇬🇧
Site 2, Bristol, United Kingdom
🇬🇧Site 1, Glasgow, United Kingdom
🇬🇧Site 3, Plymouth, United Kingdom